1 Minute Read by (Reuters) – HONG KONG (Reuters) – According to three sources with firsthand knowledge of the situation, Chinese medical data company LinkDoc Technology Ltd has postponed its US IPO in order to raise up to $211 million as a result of Beijing’s crackdown on offshore IPOs. LinkDoc, a Chinese medical data solutions provider, filed for an IPO in the United States last month and was set to price its shares after the U.S. market closed on Thursday. The decision comes after Beijing announced on Tuesday that it will enhance oversight of all Chinese companies listed abroad, a major regulatory shift that sparked a sell-off in Chinese stocks listed in the United States. Because the material has not yet been made public, the sources declined to be identified. LinkDoc, based in Beijing, did not respond to a request for comment right away. Scott Murdoch and Kane Wu contributed reporting, and Sumeet Chatterjee and Christopher Cushing edited the piece./n
Read More
